My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

AbbVie (NY:ABBV)

234.00 +1.64 (+0.71%)

Official Closing Price Updated: 7:00 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9

...

89 90 Next >

STRATA Skin Sciences Soars as Landmark Study Reveals Superior Vitiligo Treatment Efficacy

September 23, 2025

STRATA Skin Sciences Inc. (NASDAQ: SSKN) witnessed a dramatic surge in its stock price today, climbing 51.18% following the publication of a groundbreaking peer-reviewed study. The research highlights...

Via MarketMinute

Topics Intellectual Property

The Magnificent 7 Boom Just Triggered A Dot-Com Era Warning ↗

September 23, 2025

The Magnificent Seven tech giants are now worth $21 trillion—8x more than top health care stocks, echoing dot-com bubble extremes.

Via Benzinga

1 Top Dividend Stock to Buy and Hold Forever ↗

September 22, 2025

The stock has outperformed the broader market since its 2013 IPO, and can still do so over the long run.

Via The Motley Fool

Topics Economy Initial Public Offering Intellectual Property

How Do Investors Really Feel About AbbVie? ↗

September 17, 2025

Via Benzinga

AbbVie Logs Best Day In Over 7 Months As Wall Street Cheers Rinvoq Patent Deal Pushing Generics To 2037 ↗

September 12, 2025

Via Stocktwits

Topics Intellectual Property

AbbVie Stock Touches Record High After Company Dismisses Generic Competition For Rinvoq Till 2037: Wells Fargo Terms It A ‘Big Win’ ↗

September 11, 2025

Via Stocktwits

Inflation's Lingering Shadow: Long-Term Expectations Rise Amidst Fed Rate Cuts

September 22, 2025

The financial markets are currently navigating a perplexing economic landscape where long-term inflation expectations are on the rise, even as the Federal Reserve initiates interest rate cuts. In...

Via MarketMinute

Topics Bonds ETFs Economy

Johnson & Johnson's Uninterrupted Dividend Growth: Innovation in Medicine and MedTech Drives Strong Q2 2025 Performance

September 22, 2025

Johnson & Johnson (NYSE: JNJ), the global healthcare titan, has once again underscored its formidable market position and unwavering commitment to shareholder value, reporting a robust second quarter...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

What Is One of the Best Pharmaceutical Stocks to Buy Right Now? ↗

September 22, 2025

There aren't many companies in the industry that offer an excellent combination of growth and income.

Via The Motley Fool

Topics Intellectual Property

Forever Dividend Stocks: 3 Income Stocks I Never Plan to Sell ↗

September 22, 2025

Never say never? Maybe not with these great dividend stocks.

Via The Motley Fool

Topics Intellectual Property

Johnson & Johnson Unleashes Triple Threat: Bladder Cancer Breakthrough, Psoriasis Game-Changer, and Myasthenia Gravis Milestone Signal New Pharma Era

September 19, 2025

Johnson & Johnson (NYSE: JNJ) is making significant waves in the pharmaceutical landscape, announcing a trio of pivotal developments that underscore its robust pipeline and strategic focus on unmet...

Via MarketMinute

Lilly's Oncology Momentum Soars: Olomorasib Gains Breakthrough Status, Jaypirca Achieves Landmark Clinical Successes

September 19, 2025

Eli Lilly and Company (NYSE: LLY) is making significant waves in the oncology landscape with a series of major announcements concerning two of its innovative cancer therapies: Olomorasib and Jaypirca...

Via MarketMinute

3 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off ↗

September 19, 2025

Everything is going great for the stock market right now. But a plot twist could be on the way.

Via The Motley Fool

Topics Economy

Oruka Therapeutics, Up 20%, Is Trying To Take On AbbVie's Biggest Moneymaker ↗

September 17, 2025

Shares skyrocketed after the company said its drug has a half-life of about 100 days.

Via Investor's Business Daily

This Workday Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday ↗

September 17, 2025

Via Benzinga

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields ↗

September 17, 2025

Via Benzinga

$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today ↗

September 16, 2025

Via Benzinga

3 No-Brainer Dividend Stocks to Buy in September ↗

September 13, 2025

The attraction of these dividend stocks isn't limited to their dividends.

Via The Motley Fool

Topics Intellectual Property

1 Green Flag for AbbVie (ABBV) Stock Right Now ↗

September 12, 2025

Dividends are powerful portfolio boosters, and AbbVie is a dividend dynamo.

Via The Motley Fool

Topics Intellectual Property

Texas Rep. Julie Johnson Sold Up to $885K Worth of 3M Stock ↗

September 12, 2025

Via Benzinga

The Best Stocks to Invest $50,000 In Right Now ↗

September 12, 2025

These stocks have what it takes to succeed over the long run.

Via The Motley Fool

Topics Artificial Intelligence Government Intellectual Property

Why AbbVie (ABBV) Stock Is Trading Up Today

September 11, 2025

Shares of pharmaceutical company AbbVie (NYSE:ABBV) jumped 4.4% in the morning session after the company announced it settled litigation with generic drug manufacturers to extend patent protection for...

Via StockStory

Topics Intellectual Property

Why AbbVie Stock Is Jumping Today ↗

September 11, 2025

AbbVie's growth prospects are now more secure thanks to its latest news.

Via The Motley Fool

AbbVie Stock Breaks Out As Its Cash Cow Lives To Fight Another Day ↗

September 11, 2025

AbbVie stock broke out Thursday after the pharma announced it had inked a deal that will stave off generic Rinvoq until 2037.

Via Investor's Business Daily

Topics Intellectual Property

What's going on in today's session: S&P500 gap up and gap down stocks ↗

September 11, 2025

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.

Via Chartmill

Why Is AbbVie Stock Trading Higher On Thursday? ↗

September 11, 2025

AbbVie's settlement with generic rivals delays upadacitinib competition in the U.S. until at least 2037, supporting its long-term market presence.

Via Benzinga

These S&P500 stocks that are showing activity before the opening bell on Thursday. ↗

September 11, 2025

Curious about the S&P500 stocks that are showing activity before the opening bell on Thursday?

Via Chartmill

Global Growth Hits the Brakes: A Mixed Economic Picture Emerges for 2025 and Beyond

September 10, 2025

The global economy is bracing for a significant slowdown, with leading financial institutions projecting a challenging landscape for 2025 and the years to follow. A confluence of escalating trade...

Via MarketMinute

Topics Economy Supply Chain World Trade

1 Reason Every Investor Should Know About AbbVie (ABBV) ↗

September 08, 2025

This company's past ability to extend patent-protected market exclusivity for its drugs bodes well for new investors.

Via The Motley Fool

Topics Intellectual Property

3 Dividend Stocks to Double Up on Right Now ↗

September 07, 2025

Investors can feel good about upping their bets on these great dividend stocks.

Via The Motley Fool

Topics Energy Intellectual Property

< Previous 1 2 3 4 5 6 7 8 9

...

89 90 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.